IMAX CHINA(01970.HK)預期一季度由盈轉虧2600萬至2800萬美元
格隆匯4月24日丨IMAX CHINA(01970.HK)公佈,公司預期截至2020年3月31日止3個月公司擁有人應占淨虧損約2600萬美元至2800萬美元,而2019年同期為擁有人應占淨利潤約1100萬美元。
有關減少主要是由於:2020年第一季度中國內地爆發新型冠狀病毒(COVID-19)期間約自2020年1月24日起關閉中國內地全部約700家IMAX影院及影院系統安裝量減少,導致票房收入虧損的預期虧損及其他相關成本;及管理層長期再投資主張的變化以使公司在資金分配方面有更多靈活性,導致有關預扣税的非經常性、非現金遞延所得税費用2000萬美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.